latest news releases from the newsroom
Global Genomics AB
Global Genomics AB -- tangerine Gene Expression Profiling Receives Registered Trademark Status in the U.S
STOCKHOLM, Sweden, Aug. 30, 2004 (PRIMEZONE) -- Global Genomics(SM) AB has obtained a Certificate of Registration from the U.S. Patent and Trademark Office for the mark tangerine(r). Dr. Ulf Boberg, CEO of Global Genomics, stated, "This designation is another confirmation of the positive acceptance of our brand in the field of functional genomics. The company is building brand value not only with this registration, but through studies demonstrating the technology's exceptional performance in gene expression profiling."
Murray, Frank & Sailer LLP
Investor Reminder: Murray, Frank & Sailer LLP Announces Class Action Lawsuit Against salesforce.com, inc. -- CRM
NEW YORK, Aug. 27, 2004 (PRIMEZONE) -- Murray, Frank & Sailer LLP announces that a class action lawsuit was filed on behalf of all purchasers securities of salesforce.com, inc. (NYSE:CRM) ("salesforce" or the "Company") between June 21, 2004 through July 21, 2004, inclusive (the "Class Period").
Prendergast Promoted to President Of DiscLive
RICHARDSON, Texas, Aug. 27, 2004 (PRIMEZONE) -- Immediatek (OTCBB:ITEK) announced today that it has been in the process of implementing a realignment of its management structure in anticipation of greater business through its DiscLive subsidiary. Rich Isaacson continues as the CEO of DiscLive and Stephen Prendergast, currently DiscLive's West Coast GM, will assume the role of president of DiscLive. It is anticipated that he will be assigned additional duties within Immediatek and work closely with the management team.
Brower Piven, A Professional Corporation
Law Offices Of Charles J. Piven, P.A. Announces Class Action Lawsuit Against Cross Country Healthcare, Inc. -- CCRN
BALTIMORE, Aug. 27, 2004 (PRIMEZONE) -- Law Offices Of Charles J. Piven, P.A. today announced that a securities class action was commenced on behalf of shareholders who purchased, converted, exchanged or otherwise acquired the common stock of Cross Country Healthcare, Inc. (Nasdaq:CCRN) between October 25, 2001 and August 6, 2002, inclusive (the "Class Period").